Skip to main content
. 2016 Feb 1;16:12. doi: 10.1186/s12874-016-0117-3

Fig. 1.

Fig. 1

Event-free survival by mechanisms of action. a Treatment effects measured by time to event endpoint when patients receive therapies with different mechanisms of action (i.e., cancer immunotherapy, targeted therapy, and chemotherapy). b Corresponding hazard functions (i.e., risk of event of interest)